Cargando…
Current primary open-angle glaucoma treatments and future directions
Primary open-angle glaucoma (POAG) is a leading cause of blindness with no known cure. Management of the disease focuses on lowering intraocular pressure (IOP) with current classes of drugs like prostaglandin analogs, beta-blockers, alpha-agonists, and carbonic anhydrase inhibitors. These treatments...
Autores principales: | Beidoe, Gabriel, Mousa, Shaker A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484725/ https://www.ncbi.nlm.nih.gov/pubmed/23118520 http://dx.doi.org/10.2147/OPTH.S32933 |
Ejemplares similares
-
Neuroinflammation in Primary Open-Angle Glaucoma
por: Vernazza, Stefania, et al.
Publicado: (2020) -
Role of Fibronectin in Primary Open Angle Glaucoma
por: Faralli, Jennifer A., et al.
Publicado: (2019) -
Novel Pharmacologic Candidates for Treatment of Primary Open-Angle Glaucoma
por: Lu, Louise J., et al.
Publicado: (2017) -
Current status and future directions in the management of chronic hepatitis C
por: Aman, Wosen, et al.
Publicado: (2012) -
Molecular genetics of primary open-angle glaucoma
por: Yadav, Manoj, et al.
Publicado: (2023)